High class ACTA outing


CTC staff shined in the recent Australian Clinical Trials Alliance conference.

Read more

New CRE supporting innovative trials


The CTC will perform a key role in a newly announced Centre of Research Excellence (CRE) in clinical trials methodology.

Read more

Prof Stockler receives MOGA cancer achievement award


The CTC’s Prof Martin Stockler has received the prestigious MOGA Novartis Cancer Achievement Award for his outstanding contribution to medical oncology in Australia.

Read more

Back of eye holds secrets for people with diabetes


A new trial being undertaken by the NHMRC Clinical Trials Centre is photographing the back of the eye of those living with diabetes to help them avoid losing their vision and the risks of amputation and heart disease.

Read more

ENZAMET highlight at top US conference


The ANZUP-led ENZAMET trial was a stand-out success story at the recent American Society of Clinical Oncology annual conference.

Read more

Consumer partnership wins inaugural ACTA award


CTC’s partnership with Miracle Babies Foundation - a consumer body representing parents of sick newborns - has received the Australian Clinical Trials Alliance’s inaugural award for consumer engagement.

Read more

Pioneering the recruitment of preterm babies


In a long awaited study on preterm babies, the CTC and its partners have taken a pioneering path to ensure they get enough trial participants and can positively impact babies lives around the word.

Read more

Statins found to be safe and effective for the elderly


Statin therapy is safe and effective in older people over 75 years and reduces major cardiovascular events such as heart attacks and strokes, according to new research by the University of Sydney's Clinical Trials Centre published in The Lancet.

Read more

CTC investigators awarded new funding


Eleven CTC investigators were awarded new funding from the NHMRC, the ARC, the MRFF, Cure Brain Cancer, and the Danish Diabetes Academy.

Read more

Leading role in EU migration report


CTC leads review of cost-effectiveness for screening and vaccinating migrants for European Union.

Read more

New ways to kill pancreatic cancer


Pancreatic cancer could be treated using a new form of radiotherapy that delivers highly targeted doses of radiation to kill tumour cells.

Read more

Prof Tony Keech receives Vice Chancellor's Award


The award was established to celebrate exceptional performance at the University of Sydney.

Read more

Young neuro cancer patients get $1m boost


The Cooperative Trials Group for Neuro-Oncology (COGNO) at the CTC was awarded funding from CanTeen to give adolescent and young adult cancer patients access to the latest in treatment.

Read more

Lancet review calls for access to diabetes tools


In a recent review article, the CTC joins calls for better access to blood glucose meters and test strips for diabetes sufferers.

Read more

CTC Fellow wins Peter Bancroft Award


Congratulations to the CTC's Mbathio Dieng, who won a prestigious University of Sydney Faculty of Medicine Award for her PhD research into managing stress and fear of cancer recurrence in recovering, early-stage melanoma patients.

Read more

Neonatal team takes out premier ACTA award


A life-saving placental transfusion study led by CTC's Professor William Tarnow-Mordi received the Australian Clinical Trials Alliance 'Trial of the Year' Award.

Read more

Trial benefits exceed costs: report


A report authored by ACTA and an Australian Commission says trials return $5.80 for every $1 invested.

Read more